"About 65% of breast cancer patients develop mild to severe anemia due to illness or chemotherapy," says Dr. Veronika Pasquinelli, a hospital specialist at the Inselspital in Bern. The consequences are mainly depletion states that can result in the so-called "cancer fatigue syndrome".
We think very little about breast cancer: in the metastatic stage, breast cancer is almost never curable. This situation affects a large number of women, of whom there is very little talk: women over 50.
In most cases, it is in the tumor bed that the success or failure of a breast cancer operation is decided. After the excision of the tumor, the risk of restarting the tumor is greatest in the transition zone between the affected tissues and the healthy tissues. It is for this reason that radiotherapy exactly targets this area of ??the breast. Most of the time, however, conventional radiotherapy takes place several weeks after the procedure itself: the tumor bed is often not precisely achieved. With INTRABEAM, Carl Zeiss's new irradiation device, irradiation is possible directly after the operation. Early studies have shown that the risk of relapse is extremely low.
Active substances and treatments are always more ingenious against advanced HER-2 positive breast cancer. We discussed with Prof. Dr. med. Beat ThĂĽrlimann, Chief Medical Officer and Director of the Breast Center of the St. Gallen Cantonal Hospital, the latest treatment recommendations and the hopes of research for years to come.